← Leaderboards
Beth L Laube
Johns Hopkins University
$494,410
Attributed
$969,819
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $320.8K · FY2005–17$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$969,819 · 8
By mechanism
R01$950,819 · 1
M01$19,000 · 7
Top collaborators
- Pamela L. Zeitlin3 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Richard A Cone$17,702,134
- Deborah J Anderson$20,708,269
- Steven R Kleeberger$929,417
- Marsha W Wills-Karp$29,249,566
- Bradley J Undem$17,939,860
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchInhalation Drug AdministrationAerosolsHuman Therapy EvaluationPharmacokineticsCystic FibrosisRespiratory FunctionDrug Screening /EvaluationLungDeoxyribonuclease IBreathingBronchoalveolar Lavage14 Year OldBirth RateAge Of OnsetBirthChronic Lung DiseaseCystic Fibrosis PatientsChronicClinical Trial Phase IConsumable /Disposable Biomedical EquipmentChildren With Cystic FibrosisBiological Markers
Grant awards (16)
Defining the Pulmonary Attributes of Pre-symptomatic Lung Disease in Cystic Fibrosis$320,819
R01 · FY2017 · HL · contact PI
Defining the Pulmonary Attributes of Pre-symptomatic Lung Disease in Cystic Fibrosis$315,000
R01 · FY2016 · HL · contact PI
Defining the Pulmonary Attributes of Pre-symptomatic Lung Disease in Cystic Fibrosis$315,000
R01 · FY2015 · HL · contact PI
MUCOCILIARY CLEARANCE$3,288
M01 · FY2006 · RR · contact PI
STUDIES OF AEROSOL PARTICLE-RELATED AND PATIENT-$822
M01 · FY2006 · RR · contact PI
MUCOCILIARY CLEARANCE$6,230
M01 · FY2005 · RR
STUDIES OF AEROSOL PARTICLE-RELATED AND PATIENT-$2,991
M01 · FY2005 · RR
MUCOCILIARY CLEARANCE$499
M01 · FY2005 · RR
Mucociliary Clearance$2,820
M01 · FY2004 · RR
Studies of Aerosol Particle-Related and Patient-$2,350
M01 · FY2004 · RR
AIRWAY PRESSURE EFFECTS ON DEPOSITION OF RHDNASE IN CF$0
M01 · FY2002 · RR
NASAL DEPOSITION OF AEROSOL BY TWO NASAL SPRAY PUMPS$0
M01 · FY2002 · RR
AIRWAY PRESSURE EFFECTS ON DEPOSITION OF RHDNASE IN CF$0
M01 · FY2001 · RR
NASAL DEPOSITION OF AEROSOL BY TWO NASAL SPRAY PUMPS$0
M01 · FY2001 · RR
AIRWAY PRESSURE EFFECTS ON DEPOSITION OF RHDNASE IN CF$0
M01 · FY2000 · RR
NASAL DEPOSITION OF AEROSOL BY TWO NASAL SPRAY PUMPS$0
M01 · FY2000 · RR